Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 17/20 | 1.00 |
| ▸ | F2 | P00734 | 1/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.49 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.49 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21999482 | 0.88 | ACLY (0.78) | ACLY | |
| SCHEMBL13660778 | 0.81 | ACLY (0.68) | ACLY | |
| SCHEMBL22000022 | 0.80 | ACLY (1.00) | ACLY | |
| SCHEMBL7685025 | 0.74 | ACLY (0.58) | ACLY | |
| SCHEMBL17351953 | 0.73 | ACLY (0.67) | ACLYF2PRSS1PRSS2PRSS3 | |
| Phenol SCHEMBL11122022 | 0.71 | ACLY (0.55) | ACLYF2PRSS1PRSS2PRSS3 | |
| SCHEMBL22000196 | 0.70 | ACLY (1.00) | ACLY | |
| SCHEMBL14433781 | 0.70 | ACLY (0.75) | ACLY | |
| SCHEMBL21931022 | 0.69 | ACLY (1.00) | ACLY | |
| SCHEMBL21999815 | 0.69 | ACLY (1.00) | ACLYF2PRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200148634-A1 | ACLY INHIBITORS AND USES THEREOF | Nimbus Artemis, Inc. | 2020-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200148634-A1 | ACLY INHIBITORS AND USES THEREOF | ACLY, ATP5ME, ATP5MG | ACLY 1/4885F2 3257/4885PRSS1 2596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.